PubMed=15064773; DOI=10.1038/labinvest.3700080
Fosmire S.P., Dickerson E.B., Scott A.M., Bianco S.R., Pettengill M.J., Meylemans H.A., Padilla M.L., Frazer-Abel A.A., Akhtar N., Getzy D.M., Wojcieszyn J., Breen M., Helfand S.C., Modiano J.F.
Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium.
Lab. Invest. 84:562-572(2004)

PubMed=16797414; DOI=10.1016/j.exphem.2006.04.013
Lamerato-Kozicki A.R., Helm K.M., Jubala C.M., Cutter G.R., Modiano J.F.
Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation.
Exp. Hematol. 34:870-878(2006)

PubMed=19461996; DOI=10.1371/journal.pone.0005549; PMCID=PMC2680013
Tamburini B.A., Trapp S., Phang T.L., Schappa J.T., Hunter L.E., Modiano J.F.
Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed.
PLoS ONE 4:e5549.1-e5549.12(2009)

PubMed=24582862; DOI=10.1016/j.yexcr.2014.02.020; PMCID=PMC4256199
Kim J.-H., Frantz A.M., Anderson K.L., Graef A.J., Scott M.C., Robinson S., Sharkey L.C., O'Brien T.D., Dickerson E.B., Modiano J.F.
Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment.
Exp. Cell Res. 323:155-164(2014)

PubMed=30601866; DOI=10.1371/journal.pone.0210297; PMCID=PMC6314605
Dowling M., Samuelson J., Fadl-Alla B.A., Pondenis H.C., Byrum M., Barger A.M., Fan T.M.
Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
PLoS ONE 14:e0210297.1-e0210297.20(2019)